“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...

(Reuters) - Chinese autonomous driving firm Pony AI said on Thursday it was targeting a valuation of up to $4.48 billion in its initial public offering in the United States. Pony, backed by Japanese ...